scholarly journals Evoked responses to electrical stimulation of the auditory pathway during the wake/sleep cycle

1971 ◽  
Vol 35 (2) ◽  
pp. 491-500 ◽  
Author(s):  
E.H. Murphy ◽  
A. Starr
ORL ◽  
1995 ◽  
Vol 57 (6) ◽  
pp. 305-309 ◽  
Author(s):  
Mattheus W. Vischer ◽  
Victoria Bajo-Lorenzana ◽  
JinSheng Zhang ◽  
Rudolf Häusler ◽  
Eric M. Rouiller

1973 ◽  
Vol 38 (3) ◽  
pp. 320-325 ◽  
Author(s):  
Ronald R. Tasker ◽  
L. W. Organ

✓ Auditory hallucinations were produced by electrical stimulation of the human upper brain stem during stereotaxic operations. The responses were confined to stimulation of the inferior colliculus, brachium of the inferior colliculus, medial geniculate body, and auditory radiations. Anatomical confirmation of an auditory site was obtained in one patient. The hallucination produced was a low-pitched nonspecific auditory “paresthesia” independent of the structure stimulated, the conditions of stimulation, or sonotopic factors. The effect was identical to that reported from stimulating the primary auditory cortex, and virtually all responses were contralateral. These observations have led to the following generalizations concerning electrical stimulation of the somesthetic, auditory, vestibular, and visual pathways within the human brain stem: the hallucination induced in each is the response to comparable conditions of stimulation, is nonspecific, independent of stimulation site, confined to the primary pathway concerned, chiefly contralateral, and identical to that induced by stimulating the corresponding primary auditory cortex. No sensory responses are found in the brain stem corresponding to those from the sensory association cortex.


1999 ◽  
Vol 16 (3) ◽  
pp. 541-555 ◽  
Author(s):  
YI ZHANG ◽  
RICHARD D. MOONEY ◽  
ROBERT W. RHOADES

Single-unit recording and micropressure ejection techniques were used to test the effects of norepinephrine (NE) on the responses of neurons in the superficial layers (the stratum griseum superficiale and stratum opticum) of the hamster's superior colliculus (SC). Application of NE suppressed visually evoked responses by ≥30% in 75% of 40 neurons tested and produced ≥30% augmentation of responses in only 5%. The decrement in response strength was mimicked by application of the α2 adrenoceptor agonist, p-aminoclonidine, the nonspecific β agonist, isoproterenol, and the β1 agonist, dobutamine. These agents had similar effects on responses evoked by electrical stimulation of the optic chiasm and visual cortex. The α1 agonist, methoxamine, augmented the light-evoked responses of 53% of 49 SC cells by ≥30%, but had little effect on responses evoked by electrical stimulation of optic chiasm or visual cortex. The effects of adrenergic agonists upon the glutamate-evoked responses of SC cells that were synaptically “isolated” by concurrent application of Mg2+ were similar to those obtained during visual stimulation. Analysis of effects of NE on visually evoked and background activity indicated that application of this amine did not significantly enhance signal-to-noise ratios for most superficial layer SC neurons, and signal-to-noise ratios were in some cases reduced. These results indicate that NE acts primarily through α2 and β1 receptors to suppress the visual responses of SC neurons. Activation of either of these receptors reduces the responses of SC neurons to either of their two major visual inputs as well as to direct stimulation by glutamate, and it would thus appear that these effects are primarily postsynaptic.


2020 ◽  
Vol 13 (5) ◽  
pp. 1218-1225
Author(s):  
Cynthia R. Steinhardt ◽  
Pierre Sacré ◽  
Timothy C. Sheehan ◽  
John H. Wittig ◽  
Sara K. Inati ◽  
...  

1995 ◽  
Vol 109 (5) ◽  
pp. 385-389 ◽  
Author(s):  
R. Laszig ◽  
W. P. Sollmann ◽  
N. Marangos

AbstractCentral electrical stimulation of the auditory pathway can allow hearing in patients sufferingfrom deafness localized in the auditory nerve. Developments in a multi-channel auditory brainstem implant based on the Nucleus Mini 22 Cochlear implant with transcutaneous signal transmission is discussed. The devices have been implanted in nine European patients suffering from Neurofibromatosis Type 2. Preliminary speech perception results and patient satisfaction are encouraging, and the data presented include some limited open speech recognition.


1999 ◽  
Vol 78 (2) ◽  
pp. 110-117 ◽  
Author(s):  
Roland Laszig ◽  
Nicolas Marangos ◽  
Wolf-Peter Sollmann ◽  
Richard T. Ramsden

Sign in / Sign up

Export Citation Format

Share Document